Physician profile
Tyler Mumm
NPI 1013579754
$2,185.71
in general payments reported to CMS, 2019-2025
13 companies · $913 in 2025
The $913 reported for 2025 was more than what 83% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $316 · 2022: $49.06 · 2023: $562 · 2024: $346 · 2025: $913.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,821.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,820.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $526.50 | 2023-2025 | Lifevest |
| Abbott Laboratories | $366.89 | 2023-2025 | Ultreon, Aveir, Cardiomems |
| Abiomed | $344.36 | 2023-2025 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $195.57 | 2021-2025 | Jardiance |
| Sanofi-Aventis U.S. LLC | $170.87 | 2021-2022 | |
| W. L. Gore & Associates, INC. | $124.42 | 2023 | Gore Viabahn Vbx Balloon Expandable Endo |
| Shockwave Medical, INC | $114.41 | 2025 | |
| United Therapeutics Corporation | $113.64 | 2025 | Tyvaso |
| Janssen Pharmaceuticals, INC | $83.79 | 2021 | |
| Asahi Intecc USA, INC. | $57.18 | 2025 | Asahi Coronary Wires, Asahi Peripheral Vascular Wires |
| Heartflow, INC. | $45.93 | 2025 | |
| Alnylam Pharmaceuticals INC. | $23.41 | 2023 | Onpattro |
| Bridgebio Pharma, INC. | $18.74 | 2025 | Attruby |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyler Mumm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.